Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial.
暂无分享，去创建一个
G. Hortobagyi | L. Pusztai | E. Swisher | W. Barlow | A. Godwin | C. Anders | D. Hayes | J. Gralow | D. Tripathy | U. Brown-Glaberman | L. Goldstein | K. Timms | H. Pathak | P. Sharma | D. Lew | E. Rodler | S. Puhalla | M. Radke | Jieling Miao | Priyanka Sharma | Thu-Tam Huynh | C. S. Szyarto | Thu-Tam Huynh